DUBLIN, Oct 25, 2018 /PRNewswire/ --

The "Global Polio Vaccines Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Polio Vaccines Market to grow at a CAGR of 17.65% during the period 2018-2022.

Polio is a highly contagious disease caused by a human enterovirus of the Picornaviridae family, resulting in paralysis or death. Two types of polio vaccination are available, OPV and IPV. The incidence of polio has been decreasing owing to initiatives by governments globally to drive immunization against the infection. The report covers the present scenario and the growth prospects of the polio vaccines market. To calculate the market size, the report considers the revenue generated from the retail sales of polio vaccines across the globe. The report also includes a discussion of the Key vendors operating in this market.

According to the report, one driver influencing this market is the increased funding for the development of various types of polio vaccine. The global polio vaccines market has been witnessing rise in number of immunizations drives by government bodies, increased funding for polio vaccine supply, and innovative delivery systems.

One trend affecting this market is the cessation of oral polio vaccine. There is a growing need for cessation of OPV because the use of OPV can result in cases of polio due to circulating VDPV and vaccine-associated paralytic polio as oral vaccines contain weakened polioviruses.

Further, the report states that one challenge affecting this market is the lack of effective cold chain logistic. Polio vaccines require a highly maintained cold chain logistics and most countries lack effective cold chain logistic and a proper vaccine management system.

Key questions answered in this report

• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Key vendors

• Astellas Pharma
• GlaxoSmithKline
• Sanofi
• Serum Institute of India

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: PIPELINE ANALYSIS

• Pipeline analysis

PART 06: MARKET SIZING

• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 08: MARKET SEGMENTATION BY VACCINE TYPE

• Segmentation by vaccine type
• Comparison by vaccine type
• OPV - Market size and forecast 2017-2022
• IPV - Market size and forecast 2017-2022
• Market opportunity by vaccine type

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• Americas - Market size and forecast 2017-2022
• EMEA - Market size and forecast 2017-2022
• APAC - Market size and forecast 2017-2022
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 13: MARKET TRENDS

• Cessation of oral polio vaccine
• Ensuring vaccination in conflict zones and countries with weak health systems

PART 14: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/m7zbln/global_polio?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com